CO5251413A1 - Uso nuevo - Google Patents

Uso nuevo

Info

Publication number
CO5251413A1
CO5251413A1 CO00092011A CO00092011A CO5251413A1 CO 5251413 A1 CO5251413 A1 CO 5251413A1 CO 00092011 A CO00092011 A CO 00092011A CO 00092011 A CO00092011 A CO 00092011A CO 5251413 A1 CO5251413 A1 CO 5251413A1
Authority
CO
Colombia
Prior art keywords
new use
occlusive article
skin
occlusive
buffering
Prior art date
Application number
CO00092011A
Other languages
English (en)
Inventor
Bo Runeman
Jan Faergemann
Larko Olle
Original Assignee
Sca Hygiene Prod Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sca Hygiene Prod Ab filed Critical Sca Hygiene Prod Ab
Publication of CO5251413A1 publication Critical patent/CO5251413A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El uso de un ingrediente farmacéuticamente aceptable no tóxico y no irritante capaz de amortiguar dentro del rango de pH de 2,0 a 5,5 para preparar un artículo oclusivo de la piel o un artículo oclusivo de la membrana mucosa para impedir irritaciones de la piel y lesiones causadas por Candida albicans.
CO00092011A 1999-12-02 2000-12-01 Uso nuevo CO5251413A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904387A SE521431C2 (sv) 1999-12-02 1999-12-02 Användning av en pH-buffrande substans för att förhindra hudinfektioner orsakade av Candida Albicans

Publications (1)

Publication Number Publication Date
CO5251413A1 true CO5251413A1 (es) 2003-02-28

Family

ID=20417954

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00092011A CO5251413A1 (es) 1999-12-02 2000-12-01 Uso nuevo

Country Status (13)

Country Link
EP (1) EP1233746A1 (es)
JP (1) JP2003515544A (es)
KR (1) KR20020060249A (es)
AU (1) AU778633B2 (es)
BR (1) BR0016005A (es)
CA (1) CA2392102A1 (es)
CO (1) CO5251413A1 (es)
MX (1) MXPA02005211A (es)
PL (1) PL355410A1 (es)
RU (1) RU2002117294A (es)
SE (1) SE521431C2 (es)
SK (1) SK7882002A3 (es)
WO (1) WO2001039582A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630152B2 (en) 1999-04-07 2003-10-07 Shen Wei (Usa), Inc. Aloe vera glove and manufacturing method
US6274154B1 (en) 1999-04-07 2001-08-14 Belle L Chou Aloe Vera glove and manufacturing method
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20030204893A1 (en) * 2002-05-02 2003-11-06 Chou Belle L. Elastomeric flexible article and manufacturing method
US9757285B2 (en) 2011-03-07 2017-09-12 Edgewell Personal Care Brands, Llc Absorbent article including a buffer composition
DE102011106046A1 (de) 2011-06-30 2013-01-03 Paul Hartmann Ag Wundversorgungsprodukt

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794034A (en) * 1973-02-27 1974-02-26 J Jones Odor reductant body waste pad
PH23760A (en) * 1985-05-15 1989-11-03 Procter & Gamble Disposable absorbent articles
US4842593A (en) * 1987-10-09 1989-06-27 The Procter & Gamble Company Disposable absorbent articles for incontinent individuals
AU6044094A (en) * 1994-01-17 1995-08-01 Carlo Alfredo Graziani Napkin with buffer substance
SE511838C2 (sv) * 1997-06-17 1999-12-06 Sca Hygiene Prod Ab Minskning av oönskade sidoeffekter vid användning av absorberande alster med hjälp av pH-styrning
JP2001520188A (ja) * 1997-10-22 2001-10-30 ポニカウ，ジェンス 粘膜組織の炎症を治療および予防するための方法ならびに物質
EP1061964B2 (en) * 1998-03-12 2009-10-28 The Procter & Gamble Company Proton donating actives in absorbent articles

Also Published As

Publication number Publication date
KR20020060249A (ko) 2002-07-16
JP2003515544A (ja) 2003-05-07
RU2002117294A (ru) 2004-01-27
SE521431C2 (sv) 2003-11-04
CA2392102A1 (en) 2001-06-07
PL355410A1 (en) 2004-04-19
SE9904387L (sv) 2001-06-03
BR0016005A (pt) 2002-07-30
SK7882002A3 (en) 2002-12-03
AU1906301A (en) 2001-06-12
EP1233746A1 (en) 2002-08-28
WO2001039582A1 (en) 2001-06-07
MXPA02005211A (es) 2002-12-09
SE9904387D0 (sv) 1999-12-02
AU778633B2 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
DK1792610T3 (da) Terapeutiske bioadhæsive systemet med langvarig frigivelse
PL1898876T3 (pl) Preparaty mukoadhezyjne zawierające ksyloglukan, użyteczne w wyrobach medycznych i preparatach farmaceutycznych
SV2003001107A (es) Imidazotriazinas ref.lea 35368
AUPR213700A0 (en) Antiviral agents
HN2001000190A (es) Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento
RS41904A (en) Macrolides
BR0112962A (pt) Composições farmacêuticas para o tratamento de condições inflamatórias e ulcerativas dolorosas de maioria das superfìcies epiteliais tais como mucosite, estomatite e sìndrome de behcet
TWI264312B (en) Highly flexible transdermal therapeutic system with nicotine as active ingredient
CO5251413A1 (es) Uso nuevo
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral
SE0001916D0 (sv) Novel formulation
BR0210632A (pt) Tratamento de doença parasìtica
BR0011845A (pt) Complexo farmacêutico
SV2003001061A (es) Nuevos heterociclos 3 ref.lea 35361-sv
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
ES2170649B1 (es) Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
BR0009821A (pt) Emprego de derivados de maduraftalazina como inibidores de citosinas pró-inflamatórias
ES2092559T3 (es) Formulacion farmaceutica que contiene penciclovir.
AR029829A1 (es) Uso de un derivado de la caseina para la preparacion de composiciones cosmeticas, farmaceuticas y veterinarias y las composiciones asi preparadas, utiles para inhibir la adhesion de la flora patogenica a la piel
SV2002000639A (es) Alcanosulfonatos de fenoxifenilo ref. lea 34813-sv
DE50111782D1 (de) Treibgasfreie Sprayzubereitungen
AR014432A1 (es) Composicion bioadhesivas y metodos para la administracion topica de agentes activos
HUP0004475A2 (hu) Gyógyszerkészítmény
CL2004000074A1 (es) Uso de un alginato para preparar una composicion que comprende un herbicida de bipiridilio, donde el alginato sirve para reducir la toxicidad o irritacion dermica posterior al contacto de la piel con la composicion.

Legal Events

Date Code Title Description
FC Application refused